Hormones seen as risky regimen for prostate cancer
Wide use of drugs draws questions
By researchers' estimates, more than a half-million American men with prostate cancer take drugs that radically lower their testosterone levels, effectively castrating them. (Full article: 1045 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
Waiting for Twitter to feed in the latest...